Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies
Open accessThe DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Abstract
The cardiovascular system ensures the delivery of oxygen and nutrients to all cells, tissues, and organs. Under extended exposure to reduced oxygen levels, cells are able to survive through the transcriptional activation of a series of genes that participate in angiogenesis, glucose metabolism, and cell proliferation. The oxygen-sensitive transcriptional activator HIF-1 (hypoxia-inducible factor-1) is a key transcriptional mediator of the response to hypoxic conditions. The HIF-1 pathway was found to be a master regulator of angiogenesis. Whether the process is physiological or pathological, HIF-1 seems to participate in vasculature formation by synergistic correlations with other proangiogenic factors such as VEGF (vascular endothelial growth factor), PlGF (placental growth factor), or angiopoietins. Considering the important contributions of HIF-1 in angiogenesis and vasculogenesis, it should be considered a promising target for treating ischaemic diseases or cancer. In this review, we discuss the roles of HIF-1 in both physiological/pathophysiological angiogenesis and potential strategies for clinical therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Schematic representation of HIF-α gene structures and DNA binding. (a) HIF-1α and HIF-2α contain the following domains: a nuclear localisation domain (NLS), DNA binding and dimerisation domains (bHLH/PAS), oxygen-dependent degradation domain (ODDD), and cofactor interaction and transcriptional activity domains (N-TAD/C-TAD). HIF-3α lacks a C-TAD domain. NLS: nuclear localisation signal; bHLH: basic helix-loop-helix domain; PAS: Per-ARNT-Sim motif; ODDD: oxygen-dependent degradation domain; N-TAD: N-terminal transactivation domain; C-TAD: C-terminal transactivation domain. (b) Dimerisation of HIF-1α with HIF-1β under hypoxic conditions results in the formation of the HIF-1 transcription factor, which binds to hypoxia response elements (HREs) and activates the transcription of O2-dependent genes (according to [134]).](https://figures.cochat.ai/paper-figures/7f1eff6f4e4b425f9d8561e5e5c9be64/hypoxia-inducible-factor-1-in-physiological-and-pathophysiological-angiogenesis-figure-1.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the normal developmental setting, HIF-1α plays a dominant role throughout vasculogenesis, whereas HIF-2α contributes primarily to vessel remodeling and maturation during the later stages of vasculogenesis (the HIF switch) [25].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Characteristics of tumor vasculature include lack of stabilization by pericytes and smooth muscle cells and a lack of an arterial or venous phenotype that leads to leakage, poor blood flow and perfusion (Figure 3) [25].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727 · cited 2×
“Because the uterine environment is hypoxic it is thereby obvious that hypoxiamay be the primary stimulus of vessel formation [3, 4].”
BackgroundMolecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Angiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,276 · cited 1×
“growth factors that activate their receptors [5, 6].”
Mechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162 · cited 1×
“Vessel formation occurs via only two basicmechanisms: vasculogenesis and angiogenesis [2].”
BackgroundActivation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Research works printed but not linked: 1
- Folkman J. Holland J. F. Bast R. C. Jr. Morton D. L. Frei E. III Kufe D. W. Weichselbaum R. R. Tumour angiogenesis Cancer Medicine 1997 Baltimore, Md, USA Williams & Wilkins 181 204
Cited by
Items 301–400 of 650
Garcia, J., Ávila, F. R., Torres‐Guzman, R. A., Maita, K. C., Eldaly, A. S., Rinker, B. D., Zubair, A. C., Forte, A. J., & Sarabia-Estrada, R. (2022) · Journal of Clinical and Translational Research · doi:10.18053/jctres.08.202201.005 · Cited by 13
Tu, J., Zeng, Y., An, R., Sun, J., & Wen, H. (2023) · Scientific Reports · doi:10.1038/s41598-022-27176-w · Cited by 13
Sun, W., Gao, Y., Cao, Y., Lu, J., Lv, G. H., & Xu, H. (2023) · Current Medical Science · doi:10.1007/s11596-023-2750-5 · Cited by 13
SND1 , a novel co‐activator of HIF1α , promotes tumor initiation in PyMT ‐induced breast tumor
Hu, L., Zeng, Y., Xin, L., & Yang, J. (2023) · FEBS Journal · doi:10.1111/febs.16940 · Cited by 13
“HIF1 a has been reported to regulate the expression of EZH2 by acting as a transcription factor [10].”
BackgroundPharmacological modulation of HIF-1 in the treatment of neuropsychiatric disorders
Sharma, D., Khan, H., Kumar, A., Grewal, A. K., Dua, K., & Singh, T. G. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02698-3 · Cited by 13
“Under the normoxic condition, the factor inhibiting HIF-1 (FIH1) hydroxylates asparagine, preventing the interaction of HIF-1 with CBP/ p300 (CREB-binding protein/E1A binding protein p300) (Zimna and Kurpisz 2015).”
BackgroundCharacterizing the Tumor Microenvironment and Its Prognostic Impact in Breast Cancer
Zhang, W., Lee, A., Tiwari, A. K., & Yang, M. Q. (2024) · Cells · doi:10.3390/cells13181518 · Cited by 13
“Evidence suggests angiogenesis can promote the development of various cancers, such as breast [110], colorectal [111], non-small-cell lung [112], and renal cell carcinoma [113].”
BackgroundHypoxic conditions increases H2S-induced ER stress in A2870 cells
Lencesova, L., Vlček, M., Križanová, O., & Hudecová, S. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2659-4 · Cited by 13
Gene Expression Profiling of Placenta from Normal to Pathological Pregnancies
Mezouar, S., & Mège, J. (2018) · IntechOpen eBooks · doi:10.5772/intechopen.80551 · Cited by 14
“Hypoxia-inducible factor (HIF)-1α, a transcription factor known to induce transcription of genes involved in glycolysis, erythropoiesis and angiogenesis [12], was expressed at low level in villus sections of placenta.”
BackgroundVascular obliteration because of endothelial and myointimal growth in COVID‐19 patients
Valtueña, J., Martínez‐García, G., Ruíz‐Sánchez, D., Cantero, M. G., Dueñas, C., Hadi, A., Hadi, S. M., García, Á. A., de Paula, J. M. P., & López, P. M. (2020) · International Journal of Dermatology · doi:10.1111/ijd.15300 · Cited by 13
Perfluorocarbon as an adjuvant for tumor anti-angiogenic therapy: Relevance to hypoxia and HIF-1
Farhadi, P., Yarani, R., Kiani, S., & Mansouri, K. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110357 · Cited by 13
Aref, Z., & Quax, P. H. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168909 · Cited by 13
“HIF-1 regulates the expression of proangiogenic factors and is even a master stimulator of vascular endothelial growth factor [23].”
BackgroundLong non-coding RNAs in retinal neovascularization: current research and future directions
Cao, W., Zhang, N., He, X., Xing, Y., & Yang, N. (2022) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-022-05843-y · Cited by 13
Yi, H., Han, Y., Li, Q., Lin, R., Zhang, J., Yang, Y., Wang, X., & Zhang, L. (2023) · Oncology Letters · doi:10.3892/ol.2023.13990 · Cited by 12
“As aforementioned, hypoxia is a common pathological feature in solid tumors, which results from insufficient blood supply and rapid tumor growth (34).”
BackgroundSrinivasamurthy, S. K., Mittal, P., Goyal, A., Ballal, S., Maharana, L., Goyal, K., Rana, M., Ali, H., Oliver, B. G. G., Paudel, K. R., et al. (2025) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2025.127766 · Cited by 12
Chemical modulation of transcription factors
Wiedemann, B. M., Weisner, J., & Rauh, D. (2018) · MedChemComm · doi:10.1039/c8md00273h · Cited by 12
Hypoxia Boosts Aerobic Glycolysis in Carcinoma: A Complex Process for Tumour Development
Zheng, X., Fan, H. J., Liu, Y., Wei, Z., Li, X., Wang, A., Chen, W., & Lu, Y. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467214666210811145752 · Cited by 16
Vacková, I., Vavrinova, E., Musílková, J., Havlas, V., & Petrenko, Y. (2022) · Polymers · doi:10.3390/polym14132553 · Cited by 12
“In parallel, the VEGF signaling is closely connected with hypoxia and the expression of HIF1A, and the significant upregulation of the HIF1A gene during storage may explain the increase in VEGF-A secretion [54].”
BackgroundTajali, R., Eidi, A., Tafti, H. A., Pazouki, A., & Sharifi, A. M. (2022) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2023.021 · Cited by 12
Protein homeostasis in the aged and diseased heart
Mainali, N., Ayyadevara, S., Ganne, A., Reis, R. J. S., & Mehta, J. L. (2023) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2023.4 · Cited by 17
Darwish, F. M. A., Meijerink, L., Coolen, B. F., Strijkers, G. J., Bekker, M. N., Lely, A. T., & Terstappen, F. (2023) · Cells · doi:10.3390/cells12162080 · Cited by 12
Panagiotides, N. G., Poledniczek, M., Andreas, M., Hülsmann, M., Kocher, A. A., Kopp, C. W., Piechota-Polańczyk, A., Weidenhammer, A., Pávó, N., & Wadowski, P. P. (2024) · Viruses · doi:10.3390/v16010121 · Cited by 13
Co-expression of HIF-1α, MDR1 and LAPTM4B in peripheral blood of solid tumors
Rehman, Z., Fahim, A., Bhatti, A., Sadia, H., & John, P. C. L. (2019) · PeerJ · doi:10.7717/peerj.6309 · Cited by 13
Vizio, B., Bosco, O., David, E., Caviglia, G. P., Abate, M. L., Schiavello, M., Pucci, A., Smedile, A., Paraluppi, G., Romagnoli, R., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041818 · Cited by 12
“It has been reported that THPO, by enhancing the stability of HIF-1α protein [8,33], which is the primary transcriptional mediator of the hypoxic response [34], may cause a marked rise in VEGF-A release in hematopoietic progenitor cells and in cell lines that express THPOR/c-Mpl [23].”
BackgroundHypoxia/reperfusion predisposes to atherosclerosis
Finsterwalder, R., Ganesan, M. K., Niederleithner, H., Habertheuer, A., Basílio, J., Lang, I. M., Krunic, M., Wiedemann, D., & Petzelbauer, P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205067 · Cited by 12
Hypoxic microenvironment in cancer: role in metabolic reprogramming
Sureka, N., Maheshwari, R., Agravat, A., Singhal, S., Zaman, S., Rishi, B., Siraj, F., Zaheer, S., & Misra, A. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1771365 · Cited by 11
“VEGF-A promotes the proliferation, migration, and survival of endothelial cells, leading to the sprouting of new blood vessels from pre-existing vasculature (168).”
Zhang, Y., Bai, Y., Bai, J., Li, L., Gao, L., & Wang, F. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000115 · Cited by 11
Alharbi, H. O., Anwar, S., & Rahmani, A. H. (2025) · Open Life Sciences · doi:10.1515/biol-2025-1181 · Cited by 13
“Additionally, angiogenesis aids in advancing several malignant cancers [78,79].”
Vadlakonda, L., Indracanti, M., Kalangi, S. K., Gayatri, B. M., Gajula, N. N., & Reddy, A. B. M. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00566-5 · Cited by 11
Rafiei, M. M., Soltani, R., Kordi, M. R., Nouri, R., & Gaeini, A. A. (2021) · PubMed Central · doi:10.22038/ijbms.2021.55582.12427 · Cited by 11
“All steps of the vessel formation cascade are supported by HIF-1α and VEGF (39).”
BackgroundRey, F., Messa, L., Maghraby, E., Casili, G., Ottolenghi, S., Barzaghini, B., Raimondi, M. T., Cereda, C., Cuzzocrea, S., Zuccotti, G., et al. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0046 · Cited by 11
“Angpt2 emerged as upregulated in PD and it has been correlated with HIF-1 as it is transcriptionally activated with other angiogenic genes and receptors by HIF-1 expression during hypoxia (Zimna and Kurpisz, 2015).”
Wang, X.-X., Deng, S., Wu, L., Liu, Q.-Q., Zheng, G., Du, K., Dou, Q.-Y., Zheng, J., & Zhang, H. (2023) · ACS Omega · doi:10.1021/acsomega.2c07052 · Cited by 13
Wittig, F., Koch, F., Pannenberg, L., Bekeschus, S., Ramer, R., & Hinz, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020810 · Cited by 11
“…in the regulation of this factor, which in addition to VEGF is responsible for the expression of other angiogenic factors (for review, see [25]) and genes involved in virtually all aspects of tumor biology, including invasion and metastasis, but also in the tumor’s response to radiation…”
BackgroundProgress in Biological Research and Treatment of Pseudomyxoma Peritonei
Li, X., Liu, G., & Wu, W. (2024) · Cancers · doi:10.3390/cancers16071406 · Cited by 15
“HIF-1 α is degraded by ubiquitination in normal oxygen concentrations and is activated in low-oxygen environments to play an important regulatory role [170].”
BackgroundFeltran, G. D. S., da Silva, R. A., Fernandes, C. J. D. C., Ferreira, M. R., dos Santos, S. A. A., Justulin, L. A., Sosa, L. D. V., & Zambuzzi, W. F. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114136 · Cited by 12
Ghanem, L., Essayli, D., Kotaich, J., Zein, M. A., Sahebkar, A., & Eid, A. H. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31424 · Cited by 11
Poly(1-vinylimidazole) polyplexes as novel therapeutic gene carriers for lung cancer therapy
Kandasamy, G., Danilovtseva, E. N., Annenkov, V. V., & Krishnan, U. M. (2020) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.11.26 · Cited by 13
Fang, Z., Zhang, Y., Zhao, X., Jin, W., & Yu, L. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/1835898 · Cited by 12
“An increased level of activated HIF-1α upregulates VEGF expression [33], which activates the PKC and ERK pathways [34], leading to more extensive Cx43 phosphorylation.”
BackgroundChu, X., Pan, Y., Zeng, X., Wang, L., Li, Z., Yan, S., & Wang, H. (2018) · Oncology Reports · doi:10.3892/or.2018.6559 · Cited by 11
Interrogation of the tumor microenvironment by nanoparticles
Panja, P., Manne, U., Awasthi, V., Bhattacharya, R., & Mukherjee, P. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217454 · Cited by 10
Maia, J., FONSECA, B. K. S., Teixeira, N. A. A., & Correia‐da‐Silva, G. (2022) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2022.102440 · Cited by 12
Usta, G., Erzurumlu, Y., Karaca, U., Candan, İ. A., Savran, M., Aşçı, H., & Hasseyid, N. (2022) · European Journal of Ophthalmology · doi:10.1177/11206721221123878 · Cited by 10
Oley, M. H., Oley, M. C., Langi, F. L. F. G., Flapper, W. J., Islam, A. A., Hatta, M., LAIDDING, S. R., Limarga, N., & Faruk, M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19955 · Cited by 10
“Hypoxia is necessary for the initiation of angiogenesis, but a prolonged state of hypoxia affects the healing process [20].”
BackgroundThe Role of Pericytes in Inner Ear Disorders: A Comprehensive Review
Maniaci, A., Briglia, M., Allia, F., Montalbano, G., Romano, G. L., Zaoualí, M. A., Hmida, D., Gagliano, C., Malaguarnera, R., Lentini, M., et al. (2024) · Biology · doi:10.3390/biology13100802 · Cited by 11
“The pharmacological activation of HIF-1 α or the inhibition of its degradation may enhance the angiogenesis and preserve pericyte function in the inner ear [215,216].”
BackgroundChen, Y., Zhang, Y., Deng, Q., Shan, N., Peng, W., Luo, X., Zhang, H., Baker, P. N., Tong, C., & Qi, H. (2016) · Reproductive Sciences · doi:10.1177/1933719116638174 · Cited by 10
“Hypoxia is a potent angiogenic trigger that stimulates proangiogenic factor activity.(11) Reports differ on the relationship between hypoxia and the Wnt/b-catenin signaling pathway.”
Ding, L., Yang, M., Zhao, T.-L., & Lv, G. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12592 · Cited by 11
Chou, M., Karim, M., Josephs, J. S., Itzkowitz, T., Dreker, M. R., & Labadie, J. G. (2023) · Lasers in Surgery and Medicine · doi:10.1002/lsm.23706 · Cited by 10
“6 Furthermore, increased expression of VEGF and its receptors have been found in PWS lesions.”
Background[Advances in the Study of Tumor-associated Macrophages in Lung Cancer].
Qiao, Y., & Fu, E. (2022) · PubMed Central · doi:10.3779/j.issn.1009-3419.2021.102.49 · Cited by 11
Modeling breast cancer dynamics through modulable small Vessel Environment Bioreactor (sVEB)
Maiullari, F., Ceraolo, M. G., Presutti, D., Fratini, N., Galbiati, M., Fasciani, A., Giżyński, K., Bousselmi, S., Megiorni, F., Marchese, C., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123441 · Cited by 9
Cysteine Alkylation in Enzymes and Transcription Factors: A Therapeutic Strategy for Cancer
Andrés, C. M. C., Lobo, F., de la Lastra, J. M. P., Munguira, E. B., Andrés, C., & Pérez‐Lebeña, E. (2025) · Cancers · doi:10.3390/cancers17111876 · Cited by 9
“…that stimulates red blood cell production) [84]; (ii) angiogenesis (vascular endothelial growth factor (VEGF) that promotes blood vessel formation) [85], platelet-derived growth factor (PDGF) that stimulates vascular smooth muscle cell proliferation and migration [86]; (iii) glucose metabolism…”
Yao, J., Saraf, F., Rathore, V. S., Darkazanli, K., Liu, Y., Korivi, M., & Bhaskar, L. V. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1568334 · Cited by 9
Bagati, A., Hutcherson, T. C., Koch, Z., Pechette, J., Dianat, H., Higley, C., Chiu, L., Song, Y., Shah, J., Chazen, E., et al. (2020) · Oncotarget · doi:10.18632/oncotarget.27732 · Cited by 9
“HMOX-1 is a microsomal enzyme that is both induced in response to cellular stress and acts to suppress oxidative stress by reduction of ROS generation [41].”
BackgroundMethodInfluentialNovel therapies targeting hypoxia mechanism to treat pancreatic cancer
Luo, W., Qiu, J., Zheng, L., & Zhang, T. (2021) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2021.02.09 · Cited by 9
“PC is a hypo-vascular malignancy, and the pancreatic tumor microenvironment (TME) is hypoxic (4).”
BackgroundDuan, P., Huang, Y., Chen, K., Cheng, C., Wu, Z., & Wu, Y. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.60774 · Cited by 9
“It is well known that HIF-1α is a master transcription factor in the process of angiogenesis through stimulating vascular endothelial growth factor [28].”
BackgroundIndazole-Cl inhibits hypoxia-induced cyclooxygenase-2 expression in vascular smooth muscle cells
Park, C., Park, J., Shim, M. K., Rhyu, M., Yoon, B.-K., Kim, K. S., & Lee, Y. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-19-0018 · Cited by 9
“2004, Zimna & Kurpisz 2015); the phenotype conversion of VSMCs plays a major role Figure 2 In-Cl decreases reactive oxygen species (ROS) levels under conditions of hypoxia.”
BackgroundDanoy, M., Poulain, S., Jellali, R., Gilard, F., Kato, S., Plessy, C., Kido, T., Miyajima, A., Sakai, Y., & Leclerc, É. (2020) · Biochemical Engineering Journal · doi:10.1016/j.bej.2020.107490 · Cited by 10
Chen, X., Wu, C. H., Zhong, J., Shen, Y., & Zu, X. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112192 · Cited by 9
Guo, Z., Wu, X., & Fan, W. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.02.025 · Cited by 10
Tissue-Protective Mechanisms of Bioactive Phytochemicals in Flap Surgery
Weinzierl, A., Ampofo, E., Menger, M. D., & Laschke, M. W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.864351 · Cited by 9
“Under ischemic conditions, hypoxia-inducible factor (HIF)-1α is no longer degraded by proteasomes and translocates into the nucleus, in which it induces the expression of vascular endothelial growth factor (VEGF), the central cytokine stimulating angiogenesis (Zimna and Kurpisz, 2015).”
BackgroundWang, S., Yadav, A. K., Han, J., Ahn, K. S., & Jang, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116353 · Cited by 9
“HIF-1α is an angiogenic transcription factor [19], and its overexpression is partially linked to CCA survival and metastasis [20].”
BackgroundAn integrative review of nonobvious puzzles of cellular and molecular cardiooncology
Uruski, P., Matuszewska, J., Leśniewska, A., Rychlewski, D., Niklas, A. A., Mikuła‐Pietrasik, J., Tykarski, A., & Książek, K. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00451-y · Cited by 9
Ouyang, J., Sun, Y., Li, W., Zhang, W., Wang, D., Liu, X., Lin, Y., Lian, B., & Xie, L. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.02.017 · Cited by 9
Xue, T., Feng, W., Yu, H., Zhu, M., Fei, M., Bao, Y., Wang, X., Ma, W., Lv, G., Guan, J., et al. (2017) · BioMed Research International · doi:10.1155/2017/6757898 · Cited by 9
“Activation of HIF-1α under hypoxic conditions is instantaneous [23], which allows cancer cells to adapt to hypoxic environments by controlling the signal transduction cascades of plenty of downstream effectors, includingVEGF, glycolytic enzymes, glucose transporters, and erythropoietin related to angiogenesis, metabol…”
BackgroundAyoub, N. M., Sardiah, S., Al–Share, Q. Y., & Alkader, M. S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0310557 · Cited by 8
From Hypoxia to Bone: Reprogramming the Prostate Cancer Metastatic Cascade
Santos, M. D. O., Koushyar, S., Dart, D. A., & Onganer, P. U. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157452 · Cited by 8
“In hypoxia, this degradation is inhibited, allowing HIF-1 α to accumulate, dimerise with HIF-1 β (ARNT), and activate a broad array of genes involved in angiogenesis, metabolism, and survival [25,26] (Figure 1).”
Angiogenesis in skin injury repair: mechanisms, regulation, and therapeutic strategies
Mao, J., Lin, Z., Pan, Z., Huang, Y., Luo, Y., Xie, H., Yin, H., & Hu, Y. (2025) · Archives of Dermatological Research · doi:10.1007/s00403-025-04424-3 · Cited by 9
“…activation of HIF-1, which is ubiquitinated and degraded by the proteasome pathway under normoxic conditions but remains stable and activated under hypoxic conditions [64, 65] Nutrients are essential for fundamental biological processes and serve as key drivers of wound healing and tissue function.”
Etuzé, T., Repessé, Y., Vivien, D., & Dubois, F. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05894-4 · Cited by 9
“HIF-1α, in turn, induces the transcription of vascu - lar endothelial growth factor (VEGF), a central mediator of hypoxia-driven neovascularization [ 31].”
Fan, Q., Chen, F., Zhang, W., Du, E., Zhao, N., Huang, S., Guo, W., Yan, X., Chen, M., & Wei, J. (2021) · Reproductive Biology · doi:10.1016/j.repbio.2021.100567 · Cited by 8
Wang, W., Koguchi‐Yoshioka, H., Nimura, K., Watanabe, R., Tanemura, A., Fujimoto, M., & Wataya‐Kaneda, M. (2023) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.03.1688 · Cited by 8
Wittig, F., Pannenberg, L., Schwarz, R., Bekeschus, S., Ramer, R., & Hinz, B. (2023) · Cells · doi:10.3390/cells12192332 · Cited by 8
“…in the cytoplasm, HIF-α enters the nucleus and dimerizes with HIF-β to form the HIF complex, which acts as a transcription factor for hundreds of genes, including those involved in angiogenesis such as VEGF, platelet-derived growth factor (PDGF) and angiopoietin-1 (for review, see [36]).”
BackgroundWen, J. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1311 · Cited by 8
“The angiogenesis ‐ related genes that are increased in both types of IMEC subsets include VEGFR receptor genes KDR, along with potential proangiogenic genes RHOJ, 35 ETS1 36 and HIF1A 37,38 (Figure 8C,D; Table S7).”
BackgroundPotential molecular targets for the pharmacologic management of non-traumatic osteonecrosis
Cheng, E. Y., & Mirzaei, A. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2421755 · Cited by 8
“Agents that inhibit the degradation of HIF-1α positively influence angiogenesis [82].”
Khamis, A. A., El-Keiy, M. M., El-Gamal, M. M. T., Saad‐Allah, K. M., & Salem, M. M. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01678-6 · Cited by 8
“Furthermore, Hypoxia-inducible factor (HIF) is largely responsible for oxidative regulatory action and is involved in various pathological disorders [18].”
Singh, V., Singh, R. K., Goswami, P., Manna, P. P., Baul, T. S. B., Mandal, A., Singh, A. K., & Koch, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-89761-z · Cited by 8
Athanasiou, D., Voros, C., Soyhan, N., Panagou, G., Sakellariou, M., Mavrogianni, D., Bikouvaraki, E. S., Daskalakis, G., & Pappa, K. I. (2025) · Biomedicines · doi:10.3390/biomedicines13071748 · Cited by 9
“Additionally, it stabilizes HIF-1 α , a transcription factor involved in angiogenesis, glucose metabolism, and erythropoiesis [9].”
Popławski, P., Piekiełko‐Witkowska, A., & Nauman, A. (2015) · Endokrynologia Polska · doi:10.5603/ep.a2017.0052 · Cited by 8
Angiogenesis-osteogenesis coupling: a key element in bone physiology and regeneration
Boston, B., Ipe, D. S., Căpitănescu, B., Hamlet, S. M., Love, R. M., Nusem, I., Miroiu, R. I., Warnke, P. H., & Petcu, E. B. (2021) · Vascular Cell · doi:10.24238/13221-13-1-203 · Cited by 9
Harnessing Macromolecular Chemistry to Design Hydrogel Micro‐ and Macro‐Environments
Soliman, B. G., Longoni, A., Major, G. S., Lindberg, G. C. J., Choi, Y. S., Zhang, Y. S., Woodfield, T. B. F., & Lim, K. S. (2023) · Macromolecular Bioscience · doi:10.1002/mabi.202300457 · Cited by 8
Cerny, M. K., Wiesmeier, A., Hopfner, Ú., Topka, C., Zhang, W., Machens, H., van Griensven, M., Broer, N., & Duscher, D. (2021) · Journal of Tissue Viability · doi:10.1016/j.jtv.2021.02.013 · Cited by 9
“Dysfunctional vessels promote a hypoxic state, which in turn stimulates further angiogenesis [37,38].”
BackgroundCYP1A1, VEGFA and Adipokine Responses of Human Adipocytes Co-exposed to PCB126 and Hypoxia
Amine, Z. E., Mauger, J., & Imbeault, P. (2022) · Cells · doi:10.3390/cells11152282 · Cited by 9
Mu, H., Wan, W., Song, J., Kuang, R., & Deng, T. (2023) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-023-01134-3 · Cited by 8
“[29] revealed that HIF-1 participated in cell proliferation and angiogenesis by regulating oxygen homeostasis in the body and releasing a variety of angiogenic growth factors.”
BackgroundLi, S. (2018) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2018.91979 · Cited by 8
“HIF-1α protein can accumulate in endothelial cells under hypoxic conditions and bind VEGF gene promoter SENP-1 (8, 9), thus inducing VEGF expression (10-12).”
BackgroundAnti-Angiogenic Treatment in Pseudomyxoma Peritonei—Still a Strong Preclinical Rationale
Andersson, Y., Fleten, K. G., Abrahamsen, T. W., Reed, W., Davidson, B., & Flatmark, K. (2021) · Cancers · doi:10.3390/cancers13112819 · Cited by 8
“Hypoxia induced transcription factor Hif1α was detected in most cases, which is consistent with hypoxia being a major driver of the angiogenic process in PMP, and Hif1α is a known up-regulator of several pro-angiogenic factors, including VEGFA, VEGFB, VEGFC, PlGF, FGF2 and flt1 [13,14].”
BackgroundPérez-Regalado, S., León, J., & Feriche, B. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-03918-1 · Cited by 9
“Moreover, the exploration of non-pharmacological treatments based on hypoxiainduced angiogenesis can be considered as a successful strategy in various pathologies, and even in the treatment of some types of cancer (Zimna and Kurpisz 2015).”
BackgroundMedulloblastoma: novel insights into emerging therapeutic targets
Shaik, S., Maegawa, S., & Gopalakrishnan, V. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1982896 · Cited by 8
Nambiar, S. S., Ghosh, S. S., & Saini, G. K. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c00989 · Cited by 7
The Current Role of Antiangiogenics in Colorectal Cancer
Basile, D., Nardo, P. D., Daffinà, M. G., Cortese, C., Giuliani, J., & Aprile, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311605 · Cited by 7
“This factor affects a great variety of signal transduction pathways, including the up-regulation of the VEGF signaling cascade [11,13].”
The hypoxic tumor microenvironment: Functional and metabolic reprogramming of key immune populations
Ojaroodi, A. F., Shokravi, S., Eskandarzadeh, S., Ghahremanzadeh, A., Alizadeh, F., Amirikar, F., Mobayen, G., Mahrooghi, D., Lahouty, M., Shamsasenjan, K., et al. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156443 · Cited by 8
Ali, H. H., Yaseen, M. M., Al-Rawi, K. F., Alaaraji, S. F. T., & Al‐Hakeim, H. K. (2022) · Acta Biologica Szegediensis · doi:10.14232/abs.2021.2.271-283 · Cited by 7
Ren, Y., Guo, Y., Sun, B., Zhu, L., Wu, W., Liang, B., Dong, X., & Zheng, C. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.156925 · Cited by 7
Jiang, M., Li, X., & Lu, Y. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119515 · Cited by 7
Zhao, J., Wang, J., Ke, Q., Zeng, J., Li, Y., Jiang, Z., Pu, F., Zhou, T., Li, N., & Xu, P. (2025) · Evolutionary Applications · doi:10.1111/eva.70120 · Cited by 7
“Finally, it binds to the hypoxia response elements (HREs) on the target gene to ultimately initiate the expression (Zimna and Kurpisz 2015).”
Chang, D., Brown, Q., Tsui, G., He, Y., Liu, J., Shi, L., & Rodríguez‐Contreras, A. (2021) · Brain Sciences · doi:10.3390/brainsci11070944 · Cited by 8
Expression of mRNA vascular endothelial growth factor in hypospadias patients
Yuri, P., Gunadi, G., Lestari, R. P., Fardilla, F. P., & Dachlan, I. (2021) · BMC Urology · doi:10.1186/s12894-021-00930-4 · Cited by 7
“HIF-1 (hypoxia-inducible factor-1) is a key transcriptional mediator of the response to hypoxic conditions [30].”
BackgroundFenofibrate mediated activation of PPARα negatively regulates trophoblast invasion
Singh, S., Dhar, R., & Karmakar, S. (2022) · Placenta · doi:10.1016/j.placenta.2022.05.015 · Cited by 7
Does Hyperbaric Oxygenation Improve Athletic Performance?
Šet, V., & Lenasi, H. (2022) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000004281 · Cited by 7
Ricci, A., Cataldi, A., Carradori, S., & Zara, S. (2022) · Biology · doi:10.3390/biology11101450 · Cited by 7
“Considering that the invasion and migration capabilities of cancer cells are closely related to the angiogenic process, hypoxia-inducible factor 1α (HIF-1α) and vascular endothelial growth factor (VEGF) proteins expression was also estimated after 24 h of treatment with Eg5 inhibitors by means of western blot analysis.”
BackgroundInfluentialRole of Angiopoietic Coronary Endothelial Dysfunction in the Pathogenesis of Ischemic Cardiomyopathy
Петровна, Ч. С., Urazova, O. I., Shipulin, V. M., Andreev, S. L., Анатольевна, Д. О., Gladkovskaya, M. V., Litvinova, L. S., & Bubenchikov, M. A. (2023) · Biomedicines · doi:10.3390/biomedicines11071950 · Cited by 7
“HIF-1 is the central regulator of angiogenesis, since it enhances the gene transcription for several proangiogenic proteins (SDF-1, VEGF, PDGFB, Ang-1 and Ang-2) and their receptors [23], thereby preventing ischemic myocardial damage [24].”
BackgroundHypoxia-induced Factor-1α and its Role in Endometrial Cancer
Smolarz, B., ŁUKASIEWICZ, H., Samulak, D., Kołaciński, R., Langner, S., Makowska, M., & Romanowicz, H. (2024) · Anticancer Research · doi:10.21873/anticanres.17195 · Cited by 7
“Its over-expression in the body occurs during increasing metabolic stress caused by the development of cancer – during hypoxia – i.e. , a state of imbalance between the demand for oxygen and its amount supplied to the cancerous tumor (58).”
Daly, C. A., Smit, M. J., & Plouffe, B. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190988 · Cited by 8
Deletion of the foxO4 Gene Increases Hypoxia Tolerance in Zebrafish
Shi, L., Zhang, A. R., Liu, H., & Wang, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108942 · Cited by 8
“The maintenance of normal growth and reproduction of oxygen-consuming organisms is inseparable from an environment with sufficient oxygen [1].”
Background
Metadata
- Authors
- Zimna, A., & Kurpisz, M.
- Affiliations
- Institute of Human Genetics (PL)
- Corresponding author
- Kurpisz, Maciej
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-13
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC4471260
- OpenAlex
- W1597158509
- Cited by
- 604
- References
- 138
- Citations by year
- 2026: 40 · 2025: 66 · 2024: 88 · 2023: 78 · 2022: 67 · 2021: 79 · 2020: 64 · 2019: 45 · 2018: 22 · 2017: 28 · 2016: 23 · 2015: 3
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Science Centre, Poland (2012/07/N/NZ3/01687, 2014/13/B/NZ3/04646, STRATEGMED1/233624/5/NCBR/2014)
- National Centre for Research and Development (2012/07/N/NZ3/01687, 2014/13/B/NZ3/04646, STRATEGMED1/233624/5/NCBR/2014)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- HIF-1, angiogenesis, hypoxia, vascular endothelial growth factor, placental growth factor, angiopoietins, vasculogenesis, ischemic diseases, cancer, oxygen sensing, transcriptional regulation
- MeSH terms
- Placenta Growth Factor, Hypoxia, Humans, Neovascularization, Pathologic, Pregnancy Proteins, Transcriptional Activation, Cell Hypoxia, Neovascularization, Physiologic, Vascular Endothelial Growth Factor A, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.